mifepristone has been researched along with Dyslipidemias in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barr, RJ; Bean, JS; Carson, MW; Clawson, D; Coghlan, MJ; Condon, B; Dill, MJ; Kohlman, DT; Luz, JG; Maletic, M; Pustilnik, A; Sindelar, DK | 1 |
Athimulam, S; Bancos, I; Delivanis, DA | 1 |
2 other study(ies) available for mifepristone and Dyslipidemias
Article | Year |
---|---|
Indole Glucocorticoid Receptor Antagonists Active in a Model of Dyslipidemia Act via a Unique Association with an Agonist Binding Site.
Topics: Animals; Binding Sites; Cricetinae; Crystallography, X-Ray; Diet, High-Fat; Dyslipidemias; Female; Ligands; Lipids; Mesocricetus; Models, Molecular; Protein Conformation; Rats; Rats, Wistar; Receptors, Glucocorticoid; Structure-Activity Relationship; Sulfonamides | 2015 |
Modern Management of Mild Autonomous Cortisol Secretion.
Topics: 14-alpha Demethylase Inhibitors; Adrenal Cortex Neoplasms; Adrenal Insufficiency; Adrenalectomy; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Dehydroepiandrosterone Sulfate; Diabetes Mellitus, Type 2; Disease Management; Dyslipidemias; Enzyme Inhibitors; Glucocorticoids; Hormone Antagonists; Humans; Hydrocortisone; Hypertension; Incidental Findings; Ketoconazole; Metyrapone; Mifepristone; Mortality; Obesity; Osteoporosis; Postoperative Hemorrhage; Risk; Saliva; Severity of Illness Index | 2019 |